One of the other candidates was Jim O'Neill, who said, “Let’s prove efficacy after they’ve been legalized.” The other was Balaji Srinivasan, who deleted his Twitter feed to try to hide his hostility to the FDA, where he had proposed replacing the FDA with online reviews. 2/
-
-
Show this thread
-
Srinivasan, basically, proposed creating a Yelp! or Über for drugs and accused the FDA of being responsible for many deaths because it "blocked many good drugs." 3/https://sciencebasedmedicine.org/donald-trump-vs-the-fda-be-afraid-be-very-afraid-of-the-loosening-of-drug-approval-standards/ …
Show this thread -
The decline in
@US_FDA regulatory enforcement actions and warning is a feature, not a bug. It is intentional. It was always going to happen under Trump because this administration is hostile to all forms of government regulation except over women's reproductive health. 4/Show this thread -
As I said at the time, Scott Gottlieb, for all his pharma connections, was the least bad candidate at the time when he was appointed FDA Commissioner. 5/
Show this thread -
Whoever follows Gottlieb as FDA Commissioner is likely to be a Peter Thiel-backed libertarian loon who wants to dismantle the FDA in the name of "freedom," online drug reviews, figuring out if drugs work after they are approved, and let the patient beware. 6/
Show this thread -
If Trump is reelected, drug regulation by the FDA as we currently know it will likely be undermined to at least the point where we revert to a pre-1962 state in which only evidence of safety and not efficacy needs to be submitted. for drug approval. 7/7
Show this thread -
Addendum. I know that the Kefauver-Harris Amendments state that evidence of efficacy is also required, but Trump's flunkies will undermine FDA regulations to the point of, in practice, undermining that law. /end
Show this thread
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.